Publications by authors named "B Riesmeier"

Aim: Duplication of 7q34 resulting in generation of BRAF-KIAA1549 fusion transcripts is a characteristic event in pilocytic astrocytoma that may also aid distinction from diffuse astrocytic tumours. As data on BRAF-KIAA1549 fusion transcript status remain mainly limited to children, we aimed to examine the diagnostic value of BRAF-KIAA1549 fusion transcripts across all age groups.

Methods: BRAF-KIAA1549 fusion transcript status was examined using reverse transcription polymerase chain reaction on formalin-fixed paraffin-embedded samples of 105 primary pilocytic astrocytomas [median patient age: 17 years (1-74 years)].

View Article and Find Full Text PDF
Article Synopsis
  • Ependymomas are tumors derived from glial cells that exhibit distinct genetic characteristics depending on their location, with this study focusing on infratentorial ependymomas.
  • Researchers compared gene expressions in tumor cells from 15 infratentorial ependymomas to normal ependymal cells, identifying 31 genes significantly overexpressed, particularly the EVI1 gene.
  • High levels of EVI1 were linked to increased tumor cell growth and a shorter survival rate in patients with infratentorial ependymomas, suggesting it could serve as a potential prognostic marker.
View Article and Find Full Text PDF

The pathogenesis of choroid plexus papillomas, intraventricular papillary neoplasms most often occurring sporadically in children and young adults, remains poorly understood. To identify pathways operative in the development of choroid plexus papillomas, gene expression profiles obtained from laser-microdissected human choroid plexus papilloma cells (n = 7) were compared with that of normal choroid plexus epithelial cells laser microdissected from autopsy tissue (n = 8). On DNA microarray data analysis, 53 probe sets were differentially expressed in choroid plexus papilloma tumor cells (>7-fold).

View Article and Find Full Text PDF

Granulocyte-colony stimulating factor (G-CSF) receptor signaling counteracts detrimental pathways in ischemic stroke. In rodents, neuroprotection provided by the G-CSF system involves up-regulation of the G-CSF receptor and its ligand, G-CSF, during cerebral ischemia. The confirmation of a similar response in the human brain would be an important rationale for the use of G-CSF in clinical stroke trials.

View Article and Find Full Text PDF